SynAct Pharma Stock Forecast - Price Action Indicator
| SYNACT Stock | 22.20 0.40 1.83% |
SynAct Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast SynAct Pharma stock prices and determine the direction of SynAct Pharma AB's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of SynAct Pharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
At this time the value of rsi of SynAct Pharma's share price is below 20 . This usually implies that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using SynAct Pharma hype-based prediction, you can estimate the value of SynAct Pharma AB from the perspective of SynAct Pharma response to recently generated media hype and the effects of current headlines on its competitors.
SynAct Pharma after-hype prediction price | SEK 22.2 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
SynAct |
SynAct Pharma Additional Predictive Modules
Most predictive techniques to examine SynAct price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for SynAct using various technical indicators. When you analyze SynAct charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check SynAct Pharma Volatility | Backtest SynAct Pharma | Information Ratio |
SynAct Pharma Trading Date Momentum
| On January 12 2026 SynAct Pharma AB was traded for 22.20 at the closing time. The highest price during the trading period was 22.50 and the lowest recorded bid was listed for 21.25 . There was no trading activity during the period 0.0. Lack of trading volume on January 12, 2026 did not result in any price rise and fall. The trading price change to the current price is 1.58% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare SynAct Pharma to competition |
Other Forecasting Options for SynAct Pharma
For every potential investor in SynAct, whether a beginner or expert, SynAct Pharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. SynAct Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in SynAct. Basic forecasting techniques help filter out the noise by identifying SynAct Pharma's price trends.SynAct Pharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with SynAct Pharma stock to make a market-neutral strategy. Peer analysis of SynAct Pharma could also be used in its relative valuation, which is a method of valuing SynAct Pharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
SynAct Pharma AB Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of SynAct Pharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of SynAct Pharma's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
SynAct Pharma Market Strength Events
Market strength indicators help investors to evaluate how SynAct Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading SynAct Pharma shares will generate the highest return on investment. By undertsting and applying SynAct Pharma stock market strength indicators, traders can identify SynAct Pharma AB entry and exit signals to maximize returns.
SynAct Pharma Risk Indicators
The analysis of SynAct Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in SynAct Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting synact stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.32 | |||
| Standard Deviation | 3.0 | |||
| Variance | 8.98 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in SynAct Stock
SynAct Pharma financial ratios help investors to determine whether SynAct Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in SynAct with respect to the benefits of owning SynAct Pharma security.